Novoray Corporation (SHA:688300)
China · Delayed Price · Currency is CNY 87.43
+2.25 (2.64%)
Apr 30, 2026, 3:00 PM CST
Novoray Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,171 | 1,116 | 959.16 | 710.99 | 660.91 | 623.82 |
Other Revenue | - | - | 1.2 | 0.69 | 1.04 | 0.89 |
| 1,171 | 1,116 | 960.36 | 711.68 | 661.95 | 624.71 | |
Revenue Growth (YoY) | 17.46% | 16.16% | 34.94% | 7.51% | 5.96% | 54.55% |
Cost of Revenue | 696.52 | 661.94 | 573.9 | 432.97 | 402.9 | 359.6 |
Gross Profit | 474.25 | 453.56 | 386.46 | 278.71 | 259.05 | 265.11 |
Selling, General & Admin | 75.22 | 72.48 | 66.66 | 59.18 | 52.57 | 46.67 |
Research & Development | 66.26 | 64.17 | 60.4 | 47.4 | 38.5 | 35.06 |
Other Operating Expenses | -10.12 | -9.15 | 3.83 | -7.84 | 6.86 | 5.88 |
Operating Expenses | 131.37 | 127.49 | 131.57 | 98.95 | 96.5 | 87.36 |
Operating Income | 342.88 | 326.07 | 254.89 | 179.76 | 162.55 | 177.75 |
Interest Expense | - | - | -3.29 | -2.03 | -2 | -0.28 |
Interest & Investment Income | 17.2 | 15.5 | 21.46 | 14.1 | 6.68 | 13.14 |
Currency Exchange Gain (Loss) | - | - | 2.96 | 1.16 | 8.44 | -1.53 |
Other Non Operating Income (Expenses) | -19.12 | -8.12 | -0.22 | -0.27 | -0.27 | -0.21 |
EBT Excluding Unusual Items | 340.97 | 333.44 | 275.79 | 192.71 | 175.4 | 188.87 |
Gain (Loss) on Sale of Investments | 3.36 | 2.68 | -1 | 2.68 | 2.16 | 0.8 |
Gain (Loss) on Sale of Assets | 0.2 | -0.02 | -0.38 | -0.02 | -0.83 | 0.08 |
Asset Writedown | -1.75 | -1.87 | - | - | - | - |
Other Unusual Items | - | - | 11.77 | 1.99 | 16.42 | 7.65 |
Pretax Income | 342.78 | 334.23 | 286.19 | 197.36 | 193.15 | 197.4 |
Income Tax Expense | 41.54 | 41.59 | 34.81 | 23.37 | 4.91 | 24.53 |
Net Income | 301.24 | 292.64 | 251.37 | 173.99 | 188.24 | 172.87 |
Net Income to Common | 301.24 | 292.64 | 251.37 | 173.99 | 188.24 | 172.87 |
Net Income Growth | 14.66% | 16.42% | 44.47% | -7.57% | 8.89% | 55.85% |
Shares Outstanding (Basic) | 241 | 242 | 242 | 241 | 242 | 241 |
Shares Outstanding (Diluted) | 241 | 242 | 242 | 241 | 242 | 241 |
Shares Change (YoY) | -0.58% | -0.08% | 0.60% | -0.69% | 0.58% | -0.24% |
EPS (Basic) | 1.25 | 1.21 | 1.04 | 0.72 | 0.78 | 0.72 |
EPS (Diluted) | 1.25 | 1.21 | 1.04 | 0.72 | 0.78 | 0.72 |
EPS Growth | 15.32% | 16.51% | 43.62% | -6.93% | 8.26% | 56.24% |
Free Cash Flow | 132.9 | 157.16 | 165.13 | 193.93 | 85.86 | -54.55 |
Free Cash Flow Per Share | 0.55 | 0.65 | 0.68 | 0.81 | 0.35 | -0.23 |
Dividend Per Share | - | - | 0.385 | 0.385 | 0.235 | 0.216 |
Dividend Growth | - | - | - | 63.73% | 8.50% | 21.63% |
Gross Margin | 40.51% | 40.66% | 40.24% | 39.16% | 39.13% | 42.44% |
Operating Margin | 29.29% | 29.23% | 26.54% | 25.26% | 24.56% | 28.45% |
Profit Margin | 25.73% | 26.23% | 26.17% | 24.45% | 28.44% | 27.67% |
Free Cash Flow Margin | 11.35% | 14.09% | 17.19% | 27.25% | 12.97% | -8.73% |
EBITDA | 406.29 | 386.98 | 305.85 | 229.41 | 198.9 | 200.67 |
EBITDA Margin | 34.70% | 34.69% | 31.85% | 32.23% | 30.05% | 32.12% |
D&A For EBITDA | 63.4 | 60.91 | 50.96 | 49.65 | 36.36 | 22.92 |
EBIT | 342.88 | 326.07 | 254.89 | 179.76 | 162.55 | 177.75 |
EBIT Margin | 29.29% | 29.23% | 26.54% | 25.26% | 24.56% | 28.45% |
Effective Tax Rate | 12.12% | 12.44% | 12.16% | 11.84% | 2.54% | 12.43% |
Revenue as Reported | - | - | 960.36 | 711.68 | 661.95 | 624.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.